RxAnte is a health care improvement company that provides a new and innovative approach for driving medication adherence by helping organizations target, manage, and evaluate their adherence support initiatives. The company's patent-pending predictive analytics and decision support solutions turn ordinary claims data into actionable insights and management recommendations that help health care organizations deliver the right intervention to the right patient at the right time.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/12/12 | undisclosed | Series A |
Aberdare Ventures West Health Investment Fund | undisclosed |
